跳至主要内容
成分CosIng 更新 15 十月 2010

DIHYDROCOUMARIN

DIHYDROCOUMARIN 在本页关联 1 条欧盟附件记录。 清单备注:II/427。

一览

功能
Fragrance, perfuming
CAS
119-84-6
EC
204-354-9
欧盟附件
附件 II/427
科学依据:1 份 SCCS 意见

欧盟消费者安全科学委员会(SCCS)评估过该物质。其意见是附录条目的科学依据。

按市场划分的监管证据

此矩阵将已核实的成分规则与已映射但尚未导入的来源区分开。没有已导入的规则并不意味着该成分获准使用。

对比市场

滑动或横向滚动以查看所有列。

市场证据状态记录来源语言
European Union已关联证据
Prohibited entry found
打开此证据
1English and EU languages
Great Britain已关联证据
Prohibited
打开此证据
1English
Canada已关联证据
Restricted
打开此证据
1English and French
New Zealand已关联证据
Prohibited
打开此证据
1English
ASEAN已关联证据
Prohibited
打开此证据
1English and national languages
China已关联证据
Prohibited
打开此证据
1Chinese with selected English material
Japan来源已映射
Official source mapped; ingredient rule not imported
0Japanese; official English translation available
South Korea已关联证据
Prohibited
打开此证据
1Korean with some English names
United States来源已映射
Official source mapped; ingredient rule not imported
0English
Australia来源已映射
Official source mapped; ingredient rule not imported
0English
Brazil已关联证据
Prohibited
打开此证据
1Portuguese with INCI crosswalks
India已关联证据
Prohibited
打开此证据
1English and Hindi
Saudi Arabia已关联证据
Prohibited
打开此证据
1Arabic and English

DIHYDROCOUMARIN 的清单详情

INCI 名称

DIHYDROCOUMARIN

记录出处

清单参考
84648
已导入的身份
DIHYDROCOUMARIN
来源更新
15/10/2010
欧盟委员会 CosIng 来源备注

关键数据

限制
II/427
功能
  • FRAGRANCE

    Imparting an odour or taste. Creating a perceivable pleasant smell and/or masking a bad smell.

  • PERFUMING

    Used for perfume and aromatic raw materials.

化学身份与性质

CAS 119-84-6 的 PubChem 二维化学结构
CAS 119-84-6PubChem CID 660

Dihydrocoumarin

3,4-dihydrocoumarin is a chromanone that is the 3,4-dihydro derivative of coumarin. It has a role as a plant metabolite. It is functionally related to a coumarin. — ChEBI

IUPAC 名称
3,4-dihydrochromen-2-one
分子式
C9H8O2
分子量
148.16 g/mol
精确质量
148.052429494 Da
XLogP3
1.6
拓扑极性表面积
26.3 Ų
氢键供体
0
氢键受体
2
共价单元
1
已定义的立体中心
0

又称

3,4-dihydrocoumarinhydrocoumarinBenzodihydropyronemelilotin2-chromanone1,2-benzodihydropyronemelilotic lactoneMelilotine
另有 16 个已报告名称
Oxochroman2H-1-Benzopyran-2-one, 3,4-dihydro-Chroman, 2-oxo-DihydrobenzopyroneUsaf do-12Coumarin, 3,4-dihydro-Meliotine2-Hydroxydihydrocinnamic acid lactoneNCI-C55890o-hydroxydihydrocinnamic acid lactoneFEMA No. 2381Hydrocinnamic acid, o-hydroxy-, delta-lactoneNM5K1Y1BT2CHEBI:16151NSC-10121RefChem:91117
外部数据库标识符

来自其他科学数据库的证据

NIH PubChem PUG-View
标识符精确匹配660

Attributed physical-property, hazard, environmental and use annotations.

  • Substance: 3,4-Dihydrocoumarin 来源: NTP Technical Reports
  • NTP Technical Report: TR-423: Toxicology and Carcinogenesis Studies of 3,4-Dihydrocoumarin (CASRN 119-84-6) in F344/N Rats and B6C3F1 Mice (Gavage Studies) (1993 ) 来源: NTP Technical Reports
  • Peer Review Date: 06/23/92 来源: NTP Technical Reports
  • Conclusion for Male Rat: Some Evidence 来源: NTP Technical Reports
  • Conclusion for Female Rat: No Evidence 来源: NTP Technical Reports
  • Conclusion for Male Mice: No Evidence 来源: NTP Technical Reports
  • Conclusion for Female Mice: Some Evidence 来源: NTP Technical Reports
  • Summary: Under the conditions of these 2-year gavage studies, there was some evidence of carcinogenic activity of 3,4-dihydrocoumarin in male F344/N rats based on increased incidences of renal tubule adenomas and focal hyperplasia. The transitional cell carcinomas in two 600 mg/kg males may also have been chemical related. There was no evidence of carcinogenic activity of 3,4-dihydrocoumarin in female F344/N rats receiving 150, 300, or 600 mg/kg. There was no evidence of carcinogenic activity of 3,4-dihydrocoumarin in male B6C3F1 mice receiving 200, 400, or 800 mg/kg. There was some evidence of carcinogenic activity in female B6C3F1 mice based on increased incidences of hepatocellular adenoma and hepatocellular adenoma or carcinoma (combined).; 3,4-Dihydrocoumarin caused ulcers, hyperplasia, and inflammation of the forestomach, parathyroid gland hyperplasia, and increased severity of nephropathy in male rats. 来源: NTP Technical Reports
  • First Aid: EYES: First check the victim for contact lenses and remove if present. Flush victim's eyes with water or normal saline solution for 20 to 30 minutes while simultaneously calling a hospital or poison control center. Do not put any ointments, oils, or medication in the victim's eyes without specific instructions from a physician. IMMEDIATELY transport the victim after flushing eyes to a hospital even if no symptoms (such as redness or irritation) develop.; SKIN: IMMEDIATELY flood affected skin with water while removing and isolating all contaminated clothing. Gently wash all affected skin areas thoroughly with soap and water. If symptoms such as redness or irritation develop, IMMEDIATELY call a physician and be prepared to transport the victim to a hospital for treatment.; INHALATION: IMMEDIATELY leave the contaminated area; take deep breaths of fresh air. If symptoms (such as wheezing, coughing, shortness of breath, or burning in the mouth, throat, or chest) develop, call a physician and be prepared to transport the victim to a hospital. Provide proper respiratory protection to rescuers entering an unknown atmosphere. Whenever possible, Self-Contained Breathing Apparatus (SCBA) shou 来源: CAMEO Chemicals
  • Signal: Warning 来源: European Chemicals Agency (ECHA)
  • GHS Hazard Statements: H302 (> 99.9%): Harmful if swallowed [Warning Acute toxicity, oral]; H317 (97.4%): May cause an allergic skin reaction [Warning Sensitization, Skin] 来源: European Chemicals Agency (ECHA)
  • Precautionary Statement Codes: P261, P264, P270, P272, P280, P301+P317, P302+P352, P321, P330, P333+P317, P362+P364, and P501 (click each P-code to see the statement) 来源: European Chemicals Agency (ECHA)
  • ECHA C&L Notifications Summary: Aggregated GHS information provided per 1702 reports by companies from 11 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.; Information may vary between notifications depending on impurities, additives, and other factors. The percentage value in parenthesis indicates the notified classification ratio from companies that provide hazard codes. Only hazard codes with percentage values above 10% are shown. For more detailed information, please visit ECHA C&L website. 来源: European Chemicals Agency (ECHA)
  • Signal: Warning 来源: Hazardous Chemical Information System (HCIS), Safe Work Australia
  • GHS Hazard Statements: H302: Harmful if swallowed [Warning Acute toxicity, oral]; H317: May cause an allergic skin reaction [Warning Sensitization, Skin] 来源: Hazardous Chemical Information System (HCIS), Safe Work Australia
  • Precautionary Statement Codes: P261, P264, P270, P272, P280, P301+P317, P302+P352, P321, P330, P333+P317, P362+P364, and P501 (click each P-code to see the statement) 来源: Hazardous Chemical Information System (HCIS), Safe Work Australia

映射方: Existing checksum-valid CAS to unique PubChem CID match. 检索时间: 2026-08-31. 打开来源记录

科学分类和危害注释仅提供背景信息,不能取代上方所示针对具体市场的监管决定。

其他来源的覆盖范围和匹配状态
来源结果已检查
NIH PubChem PUG-View精确匹配2026-08-31

已记录的无匹配结果是该来源已被检查的有效证据;这并不表示该物质在别处不存在。

于 2026-08-31 通过校验和有效的 CAS 匹配从美国国立卫生研究院 (NIH) PubChem 检索。化学性质不能取代本页的监管决定。

欧盟官方成分名称证据

该成分名称与 2025 年欧盟官方通用成分名称词汇表完全匹配。

各市场对该物质的立场不一:在 10 个对其设有规则的市场中,有的禁用,有的在条件下准用。

禁用
European UnionGreat BritainNew ZealandASEANChinaSouth KoreaBrazilIndiaSaudi Arabia
限用
Canada

查看各市场存在分歧的所有物质

配方功能重叠的成分

其他官方和科学来源

11 个可用于核查此身份的外部数据库

DIHYDROCOUMARIN 在 CosIng 清单中的呈现方式

CosIng 清单将 DIHYDROCOUMARIN 列为化妆品成分,本页将其关联到 1 条附件记录。清单条目记录名称和标识符,而附件记录显示该物质在欧盟化妆品法规中被禁用、限用或列入准用清单的情况。

在官方数据中,DIHYDROCOUMARIN 还被标记了 2 项化妆品功能。功能标识描述预期用途,但不能取代在配方或标签工作之前对关联附件记录的监管审查。

常见问题

DIHYDROCOUMARIN 出现在欧盟 CosIng 清单中,并有关联的附件记录。请查看上方的附件记录,了解适用的限制、浓度限值和使用条件。列入附件 II 表示禁用;附件 III 表示限用;附件 IV、V 和 VI 表示在特定条件下准用。

DIHYDROCOUMARIN 的限制字段内容为:“II/427”。这是 CosIng 清单中为该成分记录的限制备注。有关权威的条件和限值,请始终参阅上方关联的附件条目。

根据欧盟 CosIng 清单,DIHYDROCOUMARIN 带有以下功能标识:

CAS 119-84-6 可能出现在多条欧盟附件记录中。查看 CAS 查询页面可显示共用该标识符的所有附件 II–VI 条目,有助于识别同一化学物质在不同附件中的监管状态。

使用 INCI 检查器在选定市场中筛查完整成分表,或在所有受支持的市场数据集中对比该物质。

DIHYDROCOUMARIN 的来源说明

本页将 DIHYDROCOUMARIN 的 CosIng 清单条目与我们数据集中的 1 条关联附件 II–VI 记录相结合;该数据集基于欧盟委员会公开的化妆品成分资料构建。

请使用本清单页面研究 DIHYDROCOUMARIN 并对比关联记录,但在作出监管决定之前,请对照现行官方来源文本和法律核实限制和法律地位。

工具与后续步骤

检查您的配方

扫描完整的 INCI 成分表,检出 DIHYDROCOUMARIN 及任何关联的欧盟附件限制或致敏原标记。

INCI 检查器

搜索相似成分

查找与 DIHYDROCOUMARIN、其标识符或相近名称变体相关的其他清单成分和附件条目。

搜索